Lamotrigine Extended-Release In Elderly Patients With Epilepsy
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine the safety and tolerability of lamotrigine (LTG)
in elderly patients with epilepsy. This study will be carried out using an extended-release
formulation of lamotrigine (LTG-XR) that will allow once-a-day dosing.